Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 6,985 | 11,696 | 3,563 | 5,520 | 7,450 |
| Operating Income | -6,985 | -11,696 | -3,563 | -5,520 | -7,450 |
| Interest Expense | 8 | 0 | 0 | 0 | 0 |
| Other Income | 144 | -336 | 50 | 186 | 89 |
| Pre-tax Income | -6,849 | -12,032 | -3,513 | -5,334 | -7,361 |
| Income Tax | 3 | 8 | 2 | 7 | 4 |
| Net Income Continuous | -6,852 | -12,040 | -3,515 | -5,341 | -7,365 |
| Net Income | $-6,852 | $-12,040 | $-3,515 | $-5,341 | $-7,365 |
| EPS Basic Total Ops | -0.31 | -0.58 | -0.18 | -0.29 | -0.40 |
| EPS Basic Continuous Ops | -0.31 | -0.58 | -0.18 | -0.29 | -0.40 |
| EPS Diluted Total Ops | -0.31 | -0.58 | -0.18 | -0.29 | -0.40 |
| EPS Diluted Continuous Ops | -0.31 | -0.58 | -0.18 | -0.29 | -0.40 |
| EBITDA(a) | $-6,985 | $-11,696 | $-3,563 | $-5,520 | $-7,450 |